Alector develops therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. It last closed at $2.33 on Nov 20, up 1.52% on the day. The next earnings report for ALEC is expected around Wed, Feb 24, 2027, after the close. For the quarter ended Sep 2026, ALEC reported EPS of $1.11 on revenue of $162.9M, with revenue up 4895.9% from a year ago. Over its last 8 reports the stock moved an average of 19.1% the session after earnings. Over the last 12 months ALEC insiders bought $0 of stock on the open market and sold $1.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is ALEC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ALEC.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ALECStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ALEC · as of the Nov 20 close · updated each morning
Uptrend
The stock is 1% above its 20 day and 11% above its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the 20 day average at $2.32, and the nearest resistance the Pivot at $2.36.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 9.3%/day
Key levels
$2.8452 week high+21.9%
$2.52Swing high (Aug 26)+8.2%
$2.45Pivot R1+5.2%
$2.36Pivot+1.3%
$2.33Last close
$2.3220 day average−0.4%
$2.30Swing low (Nov 13)−1.3%
$2.24Pivot S1−3.9%
$2.0950 day average−10.3%
$2.07200 day average−11.2%
$2.00100 day average−14.2%
$1.0952 week low−53.2%
Indicators
RSI (14)
52.14
Middle of its range
Neutral
MACD
0.12
Below its signal line
Bearish
Stochastic
46.5
Middle of its range
Neutral
ADX (14)
26.1
Trending up
Williams %R
-61.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
14.3
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.0%
Change over 10 sessions
Bullish
ATR (14)
$0.22
Typical daily range, 9.3% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityHigh, 18.4%/day
Key levels
$2.8452 week high+21.9%
$2.52Swing high (Aug 26)+8.2%
$2.45Pivot R1+5.2%
$2.36Pivot+1.3%
$2.33Last close
$2.3220 day average−0.4%
$2.30Swing low (Nov 13)−1.3%
$2.24Pivot S1−3.9%
$2.0950 day average−10.3%
$2.07200 day average−11.2%
$2.00100 day average−14.2%
$1.0952 week low−53.2%
Indicators
RSI (14)
55.66
Middle of its range
Neutral
MACD
0.08
Above its signal line
Bullish
Stochastic
64.9
Middle of its range
Neutral
ADX (14)
30.9
Trending up
Williams %R
-45.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
106.3
Oversold below −100, overbought above 100
Overbought
Rate of change
+9.1%
Change over 10 sessions
Bullish
ATR (14)
$0.43
Typical daily range, 18.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for ALEC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ALEC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ALEC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ALECHow many large options trades hit ALEC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ALEC in the last 90 days.
From SEC Form 4 filings by ALEC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALEC is in one of them and how their past ALEC trades turned out.
Alector is a biotechnology company that develops treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Its drug candidates aim to remove harmful proteins, replace missing ones, or restore normal cell function. The company also builds a proprietary technology designed to help drugs reach the brain, and it partners with drugmakers such as GSK on some programs. Based in South San Francisco, California, Alector is still testing its candidates in clinical studies.